Apollo Hospitals ready to cater to COVID 19 aftermath

New Delhi: The Apollo Hospitals Group today announced the launch of Post-COVID Recovery Clinics across the hospital network. The Post-COVID Recovery Clinics will address the rising number of patients who have recovered from COVID but are suffering from the mid and long term persistent effects of the infection.

The Post-COVID Recovery Clinics will initially be launched in Apollo hospitals treating COVID in Chennai, Madurai, Hyderabad, Bengaluru, Mysore, Kolkata, Bhubaneswar, Guwahati, Indore, Lucknow, Mumbai and Ahmedabad. The clinics will be manned by a dedicated team consisting of a Family Physician assisted by a nurse.

Over 50% of COVID patients suffer from problems that include breathlessness, chest pain and heart issues, joint pains, vision problems, and memory loss months after contracting the novel coronavirus. The Post-COVID Recovery Clinics will be manned by a team of specialists including neurologists and immunologists to help patients deal with the aftermath of COVID-19 and restore them to health. In Delhi the Post-COVID Recovery Clinic will be conducted at the Indraprastha Apollo Hospitals, in SaritaVihar.

Mr P Shivakumar, Managing Director, Indraprastha Apollo Hospitals, New Delhi said, “Many patients who have recovered from COVID-19 at our hospitals have been contacting us for symptoms that they are having, and not knowing where to go for them. To address these health issues faced by patients who have recovered from COVID-19, we have started the Post-COVID Recovery Clinics. These exclusive clinics for post-COVID care will help patients to connect to the specialised care that they need. We have laid down the guidelines and have trained the clinicians to ensure that patients get the correct treatment. The clinics will help patients recover completely from the consequences of COVID-19 and return to living life as before COVID.”

COVID-19 impacts almost all the vital organs in the body. Apart from acute events like stroke and myocardial infarction, chronic conditions like diabetes and hypertension are part of the post-COVID syndrome. A number of sudden deaths in post-covid patients have been reported and most of these are attributed to acute cardiac events.

Mr P Shivakumar further said, “COVID-19 attacks not just the lungs but other organs in the body and leaves behind lingering health issues. Some of the manifestations occur weeks and months after the treatment for acute phase is completed and patient has recovered and impact the well-being of individuals beyond the acute phase. While longer-term problems are more common among patients who have been hospitalized, even patients who have recovered from a mild case can suffer from the prolonged effects of the virus. Some of the long-term effects may be severe and disabling in nature. This specialized clinic will enable us to monitor symptoms of patients on an ongoing basis and delivery timely medical attention.”

“Before COVID-19, we were already facing a tsunami of NCDs that were responsible for over 70% of the deaths. The post-COVID syndrome is adding to this disease load and if not addressed with a special focus will lead to an increase in morbidity and mortality beyond the pandemic with a large number of chronically ill individuals who have recovered from COVID. The specialized clinics will prevent acute components of the post-COVID syndrome from progressing further and effectively manage the chronic situations which form part of the post-COVID syndrome through a patient-focused, comprehensive, tele-consult and clinic based program.” Mr P Shivakumar added.

Related Posts

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

New ‘Bible’ of Nearly ‘Ideal’ Eating hit stands to become Instant Best Seller New Delhi: You are a veritable Hamlet when it comes to the question, to eat or not…

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert